Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Elevated medical costs and policy turmoil continued to affect the financial performance of payers and providers in the second quarter. | Fierce Healthcare's Paige Minemyer and Dave Muoio break down the biggest trends shaping payer and provider performance in the second quarter and what to watch next.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

Healthcare costs continue to rise, making effective payer-provider collaboration more important than ever. Download this free…

The health insurance industry weathered a rough 2025, and the turnaround for some companies through the midpoint has surprised…

Patient collections are playing a bigger and bigger role in health systems’ total revenues, bringing a new focus on the…

As medical costs continue to rise, employers are weighing a return to policies that shift additional expense to workers,…

The number of health services deals dipped in the first half of 2026 but deal value "remained resilient" as strategic acquirers…

Health plans expect the cost of treating patients to climb in 2027, projecting the highest medical cost trend in nearly two…